However, elevated expression of TMPRSS2 was reported in bladder urothelial carcinoma (BLCA), cervical squamous cell carcinoma and endocervical adenocarcinoma (CESC), cholangiocarcinoma (CHOL), glioblastoma multiforme (GBM), kidney chromophobe (KICH), pancreatic adenocarcinoma (PAAD), prostate adenocarcinoma (PRAD) and uterine corpus endometrial carcinoma (UCEC; Figure 1B,C, Figure S1). Here, TMPRSS2 is linked to endocervical adenocarcinoma.